Search
Nintedanib (Ofev®) per al tractament de la fibrosi pulmonar idiopàtica
(2016-05)
The aim of this report is to assess the available evidence on the use of nintedanib inidiopathic pulmonary fibrosis treatment.
Macitentan (Opsumit®) per al tractament de la hipertensió arterial pulmonar
(2015-11)
This report evaluates the macitentan for the treatment of pulmonary arterial hypertension as part of a study, which evaluated the efficacy and safety of this drug against a placebo.